Sponsor pipeline

Antidote Therapeutics, Inc clinical trial pipeline

Get alerts when Antidote Therapeutics, Inc's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT07215923 A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers Thromboangiitis Obliterans (Buerger's Disease) Recruiting 2025-10-15
Get alerts when Antidote Therapeutics, Inc's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free